The worst thing someone can do is suffer in silence and assume nothing can be done. Suffering in Silence or Secretly Self-Adjusting Many GLP-1 users arent raising their symptoms with anyone, and the survey points to several overlapping reasons why: More than 1 in 5 (22%) feel digestive issues are just the price to pay to stay on the medication 14% are embarrassed to discuss symptoms like diarrhea, gas, and constipation 13% fear their provider will lower their dose or tell them to stop 11% dont want to draw attention to the fact that theyre on a GLP-1 at all For the 11% who are quietly adjusting how they take their medication without telling their provider, the survey points to a population that senses something is wrong or cannot find the right care, so is managing it on their own: 29% suspect they have an underlying condition that hasnt been diagnosed 30% dont believe their doctor would take their symptoms seriously or know how to help 22% looked for help but couldnt find the right kind of support Nobody should feel they have to choose between a medication thats helping them and their day-to-day comfort, said Dr

If I switch from Semaglutide to Tirzepatide, does the frequency change
The average weight loss of patients with a 2.4 mg semaglutide dose reached 9.6% after 12 weeks, 13.8% after six months, and approximately 15% to 20% after a year
Incorporate Regular Exercise: Physical activity complements GLP-1 effects by improving insulin sensitivity, promoting cardiovascular health, and supporting weight management
For most patients managing seasonal allergies, a non-sedating antihistamine is the preferred choice
Impact of GLP-1 Receptor Agonists on Whole-Gut Gastrointestinal Motility Using Wireless Motility Capsule: A Descriptive Single-Center Case Series